<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0851578,C0852564" disease_type="Disease or Syndrome;Mental or Behavioral Dysfunction" abbrv="">Sleep disorders</z:e> are common complaints in patients with <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> such as spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>) or <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>)--<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the frequency of <z:e sem="disease" ids="C0851578,C0852564" disease_type="Disease or Syndrome;Mental or Behavioral Dysfunction" abbrv="">sleep disorders</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> patients against controls matched by age and gender, and correlated data with demographic and clinical variables </plain></SENT>
<SENT sid="2" pm="."><plain>The main <z:e sem="disease" ids="C0851578,C0852564" disease_type="Disease or Syndrome;Mental or Behavioral Dysfunction" abbrv="">sleep disorders</z:e> evaluated were rapid eye movement (REM) sleep <z:e sem="disease" ids="C0004930" disease_type="Mental or Behavioral Dysfunction" abbrv="">behavior disorder</z:e> (RBD), <z:e sem="disease" ids="C0035258" disease_type="Disease or Syndrome" abbrv="">restless leg syndrome</z:e> (RLS), and <z:hpo ids='HP_0002189'>excessive daytime sleepiness</z:hpo> (EDS) </plain></SENT>
<SENT sid="3" pm="."><plain>We recruited 40 patients with clinical and molecular-proven <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> and 38 controls </plain></SENT>
<SENT sid="4" pm="."><plain>We used the following clinical scales to evaluate our primary outcome measures: RBD Screening Questionnaire, International RLS Rating Scale, and Epworth Sleepiness Scale </plain></SENT>
<SENT sid="5" pm="."><plain>To evaluate <z:hpo ids='HP_0001251'>ataxia</z:hpo>-related motor and non-motor features, we applied the International Cooperative <z:hpo ids='HP_0001251'>Ataxia</z:hpo> Rating Scale, the Scale for the Assessment and Rating of <z:hpo ids='HP_0001251'>Ataxia</z:hpo>, and the Unified <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's Disease</z:e> Rating Scale part III </plain></SENT>
<SENT sid="6" pm="."><plain>Psychiatric manifestations were tested with the Hamilton <z:hpo ids='HP_0000739'>Anxiety</z:hpo> Scale, and Beck <z:hpo ids='HP_0000716'>Depression</z:hpo> Inventory </plain></SENT>
<SENT sid="7" pm="."><plain>The frequency of RBD and RLS were significantly higher in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> group than in the control group (p &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>There was no difference between both groups with regard to EDS </plain></SENT>
<SENT sid="9" pm="."><plain>The accuracy of RDBSQ to discriminate between cases and controls was considered the best area under the ROC curve (0.86) </plain></SENT>
<SENT sid="10" pm="."><plain>Within-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> group analysis showed that <z:hpo ids='HP_0000739'>anxiety</z:hpo> and <z:hpo ids='HP_0000716'>depression</z:hpo> were significantly correlated with RDB, but not with RLS </plain></SENT>
<SENT sid="11" pm="."><plain>Additionally, <z:hpo ids='HP_0000716'>depression</z:hpo> was considered the best predictive clinical feature for RDB and EDS </plain></SENT>
</text></document>